PLOD1 and Ehlers-Danlos syndrome, kyphoscoliotic type 1: We aim to better understand the pathomechanism of kEDS to characterize distinguishing and overlapping molecular features underlying PLOD1-kEDS and FKBP14-kEDS, and to identify novel molecular targets that may expand treatment strategies.